Mangoceuticals MGRX
NASDAQ MGRX
$0.41 +0.02 (+5.13%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mangoceuticals (MGRX) Capital Expenditures (2023)

Mangoceuticals' (MGRX) quarterly Capital Expenditures came in at $3519.0 in Q1 2023.

Analysis

Mangoceuticals (MGRX) Capital Expenditures (2023) Analysis & Trends

Mangoceuticals has disclosed Capital Expenditures across 1 years of filings, most recently posting $3519.0 for Q1 2023.

  • In Q1 2023, Capital Expenditures changed N/A year-over-year to $3519.0; the TTM figure through Dec 2023 stood at $3519.0 (changed N/A YoY), while the FY2023 annual figure was $3519.0, changed N/A from the prior year.
  • Capital Expenditures came in at $3519.0 for Q1 2023 at Mangoceuticals.
  • In the past five years, Capital Expenditures ranged from a high of $3519.0 in Q1 2023 to a low of $3519.0 in Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn 1.73 Mn
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn 25.93 Mn
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn 325,000.00
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn 1.52 Mn
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn 27.99 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn 3.13 Mn
7 Akso Health 259.44 Mn 259.25 Mn - -
8 LifeMD 147.29 Mn 147.29 Mn - -
9 eHealth 31.71 Mn -69.34 Mn - 2.20 Mn
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3,519.00